Wealth Enhancement Advisory Services, LLC Biogen Inc. Transaction History

Wealth Enhancement Advisory Services, LLC

$49 Billion
Q1 2025

A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 19,049 shares of BIIB stock, worth $2.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

19,049

Previous 16,443 15.85%

Holding current value

$2.26 Million

Previous $2.51 Million 3.66%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	BUY	$133.43 - $153.27 $347,718 - $399,421	2,606 Added 15.85%	19,049 $2.61 Million
Q4 2024 Mar 17, 2025	BUY	$146.47 - $191.55 $1.67 Million - $2.19 Million	11,425 Added 227.68%	16,443 $2.51 Million
Q4 2024 Jan 10, 2025	BUY	$146.47 - $191.55 $11,571 - $15,132	79 Added 1.6%	5,018 $767,000
Q3 2024 Oct 23, 2024	SELL	$189.07 - $236.8 $223,669 - $280,134	-1,183 Reduced 19.32%	4,939 $957,000
Q2 2024 Jul 16, 2024	BUY	$190.52 - $236.72 $12,193 - $15,150	64 Added 1.06%	6,122 $1.42 Million
Q1 2024 Apr 15, 2024	SELL	$212.02 - $267.71 $91,804 - $115,918	-433 Reduced 6.67%	6,058 $1.31 Million
Q4 2023 Jan 30, 2024	SELL	$222.59 - $267.94 $1.23 Million - $1.48 Million	-5,520 Reduced 45.96%	6,491 $1.68 Million
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $3.04 Million - $3.43 Million	12,011 New	12,011 $3.09 Million
Q1 2023 Apr 25, 2023	BUY	$256.56 - $292.34 $1.32 Million - $1.51 Million	5,164 New	5,164 $1.44 Million
Q2 2021 Aug 10, 2021	SELL	$259.0 - $414.71 $1.05 Million - $1.68 Million	-4,048 Closed	0 $0
Q1 2021 May 12, 2021	BUY	$242.95 - $284.63 $55,635 - $65,180	229 Added 6.0%	4,048 $1.1 Million
Q4 2020 Feb 10, 2021	BUY	$236.26 - $355.63 $902,276 - $1.36 Million	3,819 New	3,819 $1.05 Million
Q2 2019 Aug 02, 2019	SELL	$219.29 - $241.72 $732,867 - $807,828	-3,342 Closed	0 $0
Q1 2019 Apr 30, 2019	SELL	$216.71 - $338.96 $152,780 - $238,966	-705 Reduced 17.42%	3,342 $769,000
Q4 2018 Feb 04, 2019	BUY	$278.5 - $352.75 $1.13 Million - $1.43 Million	4,047 New	4,047 $1.37 Million
Q3 2018 Nov 02, 2018	SELL	$293.51 - $383.83 $1.12 Million - $1.46 Million	-3,812 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$257.52 - $306.91 $981,666 - $1.17 Million	3,812 New	3,812 $1.32 Million

Others Institutions Holding BIIB

# of Institutions

1,016

Shares Held

127M

Call Options Held

1.77M

Put Options Held

2.34M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $17.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Enhancement Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Enhancement Advisory Services, LLC with notifications on news.

Account

Wealth Enhancement Advisory Services, LLC Biogen Inc. Transaction History